Condition
Oral Squamous Cell Carcinoma (OSCC) clinical trials and research
Research outlook What's coming for Oral cavity cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 6 Oral Squamous Cell Carcinoma (OSCC) clinical trials that are recruiting, at sites in 3 countries (most in China (3), India (2), Taiwan (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Oral Squamous Cell Carcinoma (OSCC) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| TROP2-targeting NIR-II probe for real-time OSCC imaging during surgery | — | Kunming, Yunnan | Recruiting | Aug 31, 2026 |
| Shoulder-sparing neck surgery: comparing levels I-III vs I-IV in oral cancer with no neck nodes | — | Kolhāpur, Maharashtra | Recruiting | Jul 24, 2026 |
| Sintilimab with chemotherapy before and after surgery for locally advanced oral squamous cell carcinoma | Phase 3 | Guangzhou, Guangdong | Recruiting | Jan 28, 2026 |
| Hydrogen water oral care after free flap reconstruction for oral cancer | — | Kaohsiung City | Recruiting | Dec 29, 2025 |
| Neoadjuvant immunochemotherapy to shrink advanced oral and oropharyngeal cancers before surgery | — | Guangzhou, Guangdong | Recruiting | Aug 21, 2025 |
| Comparing two surgical approaches for early mouth cancers | — | Mumbai, Maharashtra and 2 other locations | Recruiting | Mar 17, 2023 |
All recruiting trials (6)
-
TROP2-targeting NIR-II probe for real-time OSCC imaging during surgery
This study tests whether applying a TTP-ICG imaging probe to freshly removed oral lesion tissue can help distinguish oral squamous cell carcinoma from benign conditions in real time.
-
Shoulder-sparing neck surgery: comparing levels I-III vs I-IV in oral cancer with no neck nodes
This trial tests whether removing lymph nodes only from levels I-III is as effective as extending to level IV for adults with oral squamous cell carcinoma that has no neck metastasis.
-
Sintilimab with chemotherapy before and after surgery for locally advanced oral squamous cell carcinoma
This trial will test whether adding sintilimab to chemotherapy before and after surgery helps people with locally advanced oral squamous cell carcinoma have fewer recurrences and better survival.
-
Hydrogen water oral care after free flap reconstruction for oral cancer
A randomized trial tests whether hydrogen water oral care helps reduce inflammation and pain and improve oral bacteria after surgery for oral cancer.
-
Neoadjuvant immunochemotherapy to shrink advanced oral and oropharyngeal cancers before surgery
This project tests two cycles of neoadjuvant immunochemotherapy (tislelizumab with paclitaxel plus cisplatin or carboplatin) in people with locally advanced oral or oropharyngeal squamous cell carcinoma to see tumor response and survival outcomes.
-
Comparing two surgical approaches for early mouth cancers
This study is testing whether a less invasive surgery for early mouth cancers can provide similar survival rates while being easier on patients and more affordable than the standard approach.
Related topics
Quick answers
How many Oral Squamous Cell Carcinoma (OSCC) clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), India (2 trials), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.